|
SMURF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.753000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.203560E-04 |
| Normal-vs-Stage2 |
1.506640E-01 |
| Normal-vs-Stage3 |
3.022600E-01 |
| Normal-vs-Stage4 |
8.387800E-02 |
| Stage1-vs-Stage2 |
4.792800E-01 |
| Stage1-vs-Stage3 |
8.597700E-03 |
| Stage1-vs-Stage4 |
2.692000E-01 |
| Stage2-vs-Stage3 |
4.006600E-01 |
| Stage2-vs-Stage4 |
8.588800E-01 |
| Stage3-vs-Stage4 |
3.572800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.816140E-03 |
| Normal-vs-AfricanAmerican |
1.518770E-01 |
| Normal-vs-Asian |
4.472000E-02 |
| Caucasian-vs-AfricanAmerican |
6.860200E-01 |
| Caucasian-vs-Asian |
1.056440E-02 |
| AfricanAmerican-vs-Asian |
7.416100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.735730E-03 |
| Normal-vs-Female |
7.199500E-03 |
| Male-vs-Female |
6.371000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.381600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.750700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.300300E-02 |
| Normal-vs-Age(81-100Yrs) |
8.559400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.403800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.539800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.899400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.627600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.881900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.223000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.300700E-03 |
| Normal-vs-Grade 2 |
1.783550E-03 |
| Normal-vs-Grade 3 |
4.001800E-02 |
| Normal-vs-Grade 4 |
1.255810E-01 |
| Grade 1-vs-Grade 2 |
3.237800E-01 |
| Grade 1-vs-Grade 3 |
1.995370E-01 |
| Grade 1-vs-Grade 4 |
1.734620E-01 |
| Grade 2-vs-Grade 3 |
1.946750E-01 |
| Grade 2-vs-Grade 4 |
4.859800E-01 |
| Grade 3-vs-Grade 4 |
8.494400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.281800E-03 |
| Normal-vs-ccB subtype |
2.583600E-04 |
| ccA subtype-vs-ccB subtype |
4.109600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.565400E-04 |
| Normal-vs-N1 |
1.450230E-01 |
| N0-vs-N1 |
6.159600E-01 |
|
|
